EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations

Eleonora Pozzi iD, Maria Pina Serra iD, Marianna Boi iD, Annalisa Canta, Alessia Chiorazzi, Chiara Capelli, Chiara Invernizzi, Elisa Ballarini, Virginia Rodriguez-Menendez, Margherita Francesca Kraus, Marina Quartu, Guido Cavaletti iD und 1 weitere

Journal of the Peripheral Nervous System · 2025

DOI: 10.1111/jns.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Eleonora Pozzi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurology Unit, School of Medicine and Surgery, Monza, Italy. Hauptthemen laut MEDLINE: Oxaliplatin, Neurotoxicity Syndromes, Antineoplastic Agents, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Cariplo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Oxaliplatin (OHP) induced peripheral neurotoxicity (OIPN) is a complex spectrum comprising an acute and a chronic form. Acute OIPN leads to unpleasant transient sensations in the 24–72 h after chemotherapy, due to a temporary dysfunction in ion channels (i.e., axonal hyperexcitability in the absence of anatomical damage). Whereas chronic OIPN is characterized by painful manifestations. Literature data showed that a more pronounced acute OIPN could be an early predictor of chronic OIPN; thus, acute OIPN is becoming a possible target to prevent chronic OIPN. We went back to the bench side to characterize the complexity of painful phenomena experienced by OHP‐treated patients.

Methods

Female OHP‐treated (3 mg/Kg, 2qwx4ws, iv) and control rats ( n = 10/group) were studied. Acute OIPN was detected via nerve excitability testing (NET), whereas chronic OIPN was assessed via behavioral tests, nerve conduction studies (NCS), and neuropathology (including immunohistochemistry on lumbar spinal cord specimens) both at the end of the full chemotherapy treatment (4 weeks) and at 6 weeks of follow‐up. NET was also performed 1 week after treatment completion.

Results

NET alterations related to acute OIPN were resolved within a week after chemotherapy. Whereas, chronic OIPN encountered only partial recovery over time, with prominent small fiber damage. Immunolabeling of the spinal cord at the end of treatment and after the follow‐up period was consistent with persistent neuropathic pain.

Interpretation

Our data supports the statement that unpleasant manifestations due to acute and chronic OIPN mirror different underlying phenomena and assessment as two separate entities should be considered in both clinical and preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxaliplatinNeurotoxicity SyndromesAntineoplastic AgentsPeripheral Nervous System DiseasesNeuralgiaAnimalsFemaleRatsNeural ConductionSpinal Cord

Stichwörter der Autor:innen

TRPV1hyperexcitabilityimmunolabellingnerve excitability testingneuropathic painoxaliplatin neuropathyoxaliplatin neurotoxicity

Substanzen

OxaliplatinAntineoplastic Agents

Autor:innen und Institutionen

  • Experimental Neurology Unit, School of Medicine and Surgery, Monza, Italy.
  • NeuroMI (Milan Center for Neuroscience), Milan, Italy.
  • Section of Cytomorphology, Department of Biomedical Sciences, University of Cagliari, Italy.
  • Istituto di Scienze e Tecnologie Chimiche "Giulio Natta" SCITEC CNR, Milan, Italy.
  • PhD Program in Neuroscience, University of Milano-Bicocca, Monza, Italy.

ORCID-Profile: Eleonora Pozzi, Maria Pina Serra, Marianna Boi, Guido Cavaletti, Paola Alberti

Förderung

  • Fondazione Cariplo

Zitieren

APA

Pozzi, E., Serra, M. P., Boi, M., Canta, A., Chiorazzi, A., Capelli, C., Invernizzi, C., Ballarini, E., Rodriguez-Menendez, V., Kraus, M. F., Quartu, M., Cavaletti, G., & Alberti, P. (2025). Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70078

Vancouver

Pozzi E, Serra MP, Boi M, Canta A, Chiorazzi A, Capelli C, et al. Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70078

BibTeX
@article{Pozzi2025,
  author = {Pozzi, Eleonora and Serra, Maria Pina and Boi, Marianna and Canta, Annalisa and Chiorazzi, Alessia and Capelli, Chiara and Invernizzi, Chiara and Ballarini, Elisa and Rodriguez-Menendez, Virginia and Kraus, Margherita Francesca and Quartu, Marina and Cavaletti, Guido and Alberti, Paola},
  title = {Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations},
  journal = {Journal of the Peripheral Nervous System},
  year = {2025},
  doi = {10.1111/jns.70078}
}
Kostenlos starten →